- Home
- WRAP vs GNTA Comparison
WRAP vs GNTA Comparison
Compare WRAP & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- GNTA
- Stock Information
- Founded
- WRAP 2016
- GNTA 2014
- Country
- WRAP United States
- GNTA Italy
- Employees
- WRAP N/A
- GNTA N/A
- Industry
- WRAP Ordnance And Accessories
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRAP Industrials
- GNTA Health Care
- Exchange
- WRAP Nasdaq
- GNTA Nasdaq
- Market Cap
- WRAP 68.8M
- GNTA 67.4M
- IPO Year
- WRAP N/A
- GNTA 2021
- Fundamental
- Price
- WRAP $1.70
- GNTA $5.34
- Analyst Decision
- WRAP
- GNTA Strong Buy
- Analyst Count
- WRAP 0
- GNTA 1
- Target Price
- WRAP N/A
- GNTA $25.00
- AVG Volume (30 Days)
- WRAP 191.1K
- GNTA 28.4K
- Earning Date
- WRAP 10-15-2024
- GNTA 01-01-0001
- Dividend Yield
- WRAP N/A
- GNTA N/A
- EPS Growth
- WRAP N/A
- GNTA N/A
- EPS
- WRAP N/A
- GNTA N/A
- Revenue
- WRAP $7,269,000.00
- GNTA N/A
- Revenue This Year
- WRAP N/A
- GNTA N/A
- Revenue Next Year
- WRAP N/A
- GNTA N/A
- P/E Ratio
- WRAP N/A
- GNTA N/A
- Revenue Growth
- WRAP 0.99
- GNTA N/A
- 52 Week Low
- WRAP $1.21
- GNTA $2.20
- 52 Week High
- WRAP $7.01
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- WRAP 56.79
- GNTA 56.89
- Support Level
- WRAP $1.71
- GNTA $4.89
- Resistance Level
- WRAP $1.93
- GNTA $6.20
- Average True Range (ATR)
- WRAP 0.16
- GNTA 0.70
- MACD
- WRAP 0.01
- GNTA -0.06
- Stochastic Oscillator
- WRAP 61.70
- GNTA 37.32
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.